Aquatic Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Aquatic Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.99M	Buy	+16,297	New	+$3.53M	0.14%	190
2025 Q4	–	Sell	-7,426	Closed	-$902K	–	1406
2025 Q3	$902K	Sell	7,426 -16,208	-69%	-$1.83M	0.02%	701
2025 Q2	$2.47M	Sell	23,634 -23,812	-50%	-$2.52M	0.05%	415
2025 Q1	$5.53M	Buy	47,446 +46,543	+5,154%	+$5.3M	0.14%	195
2024 Q4	$76.4K	Buy	+903	New	+$83K	﹤0.01%	1114
2024 Q3	–	Sell	-5,200	Closed	-$419K	–	1145
2024 Q2	$419K	Buy	+5,200	New	+$385K	0.02%	583
2024 Q1	–	Sell	-14,100	Closed	-$1.12M	–	1226
2023 Q4	$1.12M	Buy	+14,100	New	+$943K	0.03%	449
2023 Q2	–	Sell	-4,500	Closed	-$278K	–	1332
2023 Q1	$278K	Buy	+4,500	New	+$296K	0.02%	522
2022 Q2	–	Sell	-700	Closed	-$29K	–	1197
2022 Q1	$29K	Buy	+700	New	+$21.7K	0.04%	397

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aquatic Capital Management's AXSM Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 16,297 shares worth $3.99M. The stake represents 0.14% of the portfolio and ranks #190 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in AXSM as recently as Q3 2025.

Aquatic Capital Management first reported a position in AXSM in Q1 2022 and has held it in 9 quarters since. The position peaked at $5.53M in Q1 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Aquatic Capital Management held 16,297 shares of Axsome Therapeutics worth $3.99M as of Q2 2026.
Axsome Therapeutics was a new Aquatic Capital Management position in Q2 2026.
Axsome Therapeutics made up 0.14% of Aquatic Capital Management's portfolio in Q2 2026, its #190 holding.
Aquatic Capital Management first reported a position in Axsome Therapeutics in Q1 2022 and has held it in 9 quarters since.
Aquatic Capital Management's Axsome Therapeutics position peaked at $5.53M in Q1 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.